IQ Genomix was founded by a team of experienced scientists with deep expertise in molecular diagnostics, biotechnology and applied medical research. The company’s founders have actively contributed to the establishment and operation of molecular biology laboratories across various European countries, participating in scientific projects that enhance modern diagnostic technology.

With a vision to empower the importance of prevention, IQ Genomix aims to make the most advanced and specialized methods for early cancer detection accessible. We believe that early detection is the most effective tool for achieving better therapeutic outcomes and improving patient quality of life.

For detailed scientific information, you can contact our specialized department at: scientific@iqgenomix.com